The Cancer

Don't Miss

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

How Most cancers Stole My Peace of Thoughts and Taught Me Resilience

Being robbed is simply part of life.Once I was in grammar college, little girls and boys would copy off my exams, stealing my solutions to...

FDA Clears PD-L1 Check to Information Keytruda Use in Ovarian Most cancers

The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...

Vital Information

Facts

Latest Articles

New Remedy to Be Authorised

Zolbetuximab is a brand new drug for the therapy of gastric most cancers. In trials, it confirmed important enchancment in survival charges. The...

Meals to eat and keep away from

No single meals or food plan can stop or trigger breast most cancers. Nonetheless, an individual’s dietary selections could make a distinction of...

Day by day Aspirin Could Assist Stop Unfold of Colorectal Most cancers

Aspirin could play a task in colorectal most cancers prevention and remedy, in accordance with new analysis revealed within the journal Most...

Yale Hosts Annual Lung Most cancers SPORE Workshop < Yale College of Drugs

On June 12 – 13, 2024, Yale Most cancers Middle and Smilow Most cancers Hospital hosted the annual Lung Most cancers SPORE Workshop...

Integrative multi-region molecular profiling of major prostate most cancers in males with synchronous lymph node metastasis

Mapping major prostate most cancers to synchronous LN metastasisFrom a cohort of 18 sufferers (age 50–73 years) who had radical prostatectomy and pelvic...

Hot Topics